Healthcare - Biotechnology - NASDAQ - US
$ 1.69
-1.17 %
$ 81.6 M
Market Cap
-1.37
P/E
CASH FLOW STATEMENT
-79.7 M
OPERATING CASH FLOW
64.1 M
INVESTING CASH FLOW
76 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ikena Oncology, Inc.
| Net Income | -68.2 M |
| Depreciation & Amortization | 1.02 M |
| Capital Expenditures | -414 K |
| Stock-Based Compensation | 7.63 M |
| Change in Working Capital | -21.7 M |
| Others | -17.4 M |
| Free Cash Flow | -80.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (68.2) | (68.8) | (34.1) | (44.3) | (16.8) | (40.9) |
| Depreciation & Amortization | 1.0 | 0.8 | 0.5 | 0.3 | 0.2 | 0.4 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 7.6 | 7.5 | 5.2 | 1.8 | 1.2 | 0.3 |
| Other Operating Activities | 1.4 | 1.5 | 1.2 | 12.1 | (0.1) | 29.0 |
| Change in Working Capital | (21.7) | (15.1) | (33.0) | (7.8) | 63.5 | 58 K |
| Cash From Operations | (79.7) | (74.1) | (60.3) | (37.8) | 47.9 | (11.6) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.4) | (1.4) | (1.8) | (0.8) | (0.3) | (0.3) |
| Other Items | 64.6 | (97.9) | 0 | 3.7 | 0 | 11.3 |
| Cash From Investing Activities | 64.1 | (99.3) | (1.8) | 2.9 | (0.3) | 11.0 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | (0.7) | 0 | 0 | 57 K | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 39.2 | 1.1 | 0.4 | 116.2 | 16.3 | 0 |
| Cash From Financing Activities | 76.0 | 1.1 | 131.7 | 116.2 | 16.3 | 0 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 60.4 | (172.3) | 69.7 | 81.3 | 63.9 | (0.6) |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (80.2) | (75.5) | (62.0) | (38.6) | 47.6 | (11.9) |